GuruFocus Premium Membership

Serving Intelligent Investors since 2004. Only 96 cents a day.

Free Trial

Free 7-day Trial
All Articles and Columns »

Repros Therapeutics Inc. (RPRX) CEO Joseph Podolski buys 4,000 Shares

March 05, 2009 | About:

CEO of Repros Therapeutics Inc. (RPRX) Joseph Podolski buys 4,000 shares of RPRX on 03/05/2009 at an average price of $6.41 a share.

Zonagen Inc. is a biopharmaceutical company engaged in the development of products for the human reproductive system including sexual dysfunction vaccine adjuvants products for fertility and female health as well as urological applications specifically prostate cancer. Zonagen's products to treat sexual dysfunction all incorporate phentolamine mesylate an alpha-adrenergic blocker as the active agent. Zonagen's lead product VASOMAX(R) is a rapidly disintegrating oral formulation of phentolamine for the treatment of male erectile dysfunction. Repros Therapeutics Inc. has a market cap of $114.12 million; its shares were traded at around $5.93 with and P/S ratio of 75.67. Repros Therapeutics Inc. had an annual average earning growth of 2.3% over the past 10 years.

Recent Trades of Repros Therapeutics Inc. by CEO:


  • Buy: CEO Joseph Podolski bought 4,000 shares of RPRX stock on 03/05/2009 at the average price of $6.41; the price of the stock has decreased by 7.49% since.
  • Buy: President and CEO, Director Joseph Podolski bought 4,400 more shares of RPRX stock on 10/07/2008 at the average price of $7.14; the price of the stock has decreased by 16.95% since.


Recent Trades of Repros Therapeutics Inc. by CFO:


  • Buy: VP & CFO, Director Louis Jr Ploth bought 2,800 shares of RPRX stock on 10/07/2008 at the average price of $7.15; the price of the stock has decreased by 17.06% since.


Recent Trades of Repros Therapeutics Inc. by Directors and Officers:


  • Buy: Director Jeffrey R Harder bought 400 shares of RPRX stock on 11/18/2008 at the average price of $9.79; the price of the stock has decreased by 39.43% since.
  • Buy: Director, 10% Owner Mark Lappe bought 11,300 shares of RPRX stock on 10/31/2008 at the average price of $7.76; the price of the stock has decreased by 23.58% since.
  • Buy: 10% Owner Capital, Ltd. Efficacy bought 11,300 shares of RPRX stock on 10/31/2008 at the average price of $7.76; the price of the stock has decreased by 23.58% since.
  • Buy: Director, 10% Owner Mark Lappe bought 34,292 shares of RPRX stock on 10/29/2008 at the average price of $6.94; the price of the stock has decreased by 14.55% since.
  • Buy: 10% Owner Capital, Ltd. Efficacy bought 34,292 shares of RPRX stock on 10/29/2008 at the average price of $6.94; the price of the stock has decreased by 14.55% since.


  • CEO Buys, CFO Buys: Stocks that are bought by their CEO/CFOs.
  • Insider Cluster Buys: Stocks that multiple company officers and directors have bought.
  • Double Buys:: Companies that both Gurus and Insiders are buying
  • Triple Buys: Companies that both Gurus and Insiders are buying, and Company is buying back.

» Take a Free Trial of Premium Membership


Rating: 3.5/5 (2 votes)

Comments

Please leave your comment:


Get WordPress Plugins for easy affiliate links on Stock Tickers and Guru Names | Earn affiliate commissions by embedding GuruFocus Charts
GuruFocus Affiliate Program: Earn up to $400 per referral. ( Learn More)
Free 7-day Trial
FEEDBACK